HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

vasoactive intestinal peptide (6-28)

vasoactive intestinal peptide fragment

Also Known As:

VIP (6-28)

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Brack, Kieran E: 1 article (08/2011)
2.	Coote, John H: 1 article (08/2011)
3.	Ng, G André: 1 article (08/2011)
4.	Borda, Enri: 1 article (12/2009)
5.	Busch, Lucila: 1 article (12/2009)
6.	Miozza, Valeria: 1 article (12/2009)
7.	Sterin-Borda, Leonor: 1 article (12/2009)
8.	Markos, F: 1 article (11/2006)
9.	Snow, H M: 1 article (11/2006)

Related Diseases

1.	Ventricular Fibrillation 08/01/2011 - "Using the isolated innervated rabbit heart, we measured ventricular NO release using 4,5-diaminofluorescein (DAF-2) fluorescence and ventricular fibrillation threshold (VFT) during VNS after muscarinic, ganglionic, and VIP inhibition [atropine, hexamethonium, and VIP (6-28), respectively] and after Triton-X endothelial functional dysfunction. "
2.	Tachycardia (Tachyarrhythmias) 11/01/2006 - "Vagal postganglionic stimulation after atenolol (1 mg/kg) and hexamethonium (10 mg/kg) caused a bradycardia (40 beats/min, n = 2), after atropine (0.5 mg/kg i.v.) the resulting tachycardia (37 beats/min) was attenuated by VIP receptor antagonism with VIP (6-28) (100 mug i.c.) by approximately 50%. "
3.	Periodontitis 12/01/2009 - "Parotid glands from rats with periodontitis showed an increase in cAMP levels that was also reverted in the presence of SQ 22536, FR 122047 and VIP 6-28. "
4.	Bradycardia 11/01/2006 - "Vagal postganglionic stimulation after atenolol (1 mg/kg) and hexamethonium (10 mg/kg) caused a bradycardia (40 beats/min, n = 2), after atropine (0.5 mg/kg i.v.) the resulting tachycardia (37 beats/min) was attenuated by VIP receptor antagonism with VIP (6-28) (100 mug i.c.) by approximately 50%. "

Related Drugs and Biologics

1.	Hexamethonium (Hexamethonium Bromide)
2.	Atropine
3.	Cholinergic Agents (Cholinergics)
4.	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)
5.	Atenolol (Tenormin)
6.	4,5-diaminofluorescein
7.	1- ((4,5- bis(4- methoxyphenyl)- 2- thiazoyl)carbonyl)- 4- methylpiperazine
8.	9-(tetrahydro-2-furyl)-adenine